Corrigendum to “In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies” (European Journal of Pharmaceutics and Biopharmaceutics (2014) 88(1) (238–251), (S0939641114001349), (10.1016/j.ejpb.2014.04.017));In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 1, 2014, Pages 238-251

  Anitha, A ^a   Sreeranganathan, Maya ^a   Chennazhi, Krishna Prasad ^a   Lakshmanan, Vinoth Kumar ^a   Jayakumar, R ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

(N O CMC NPs); 5 Fluorouracil (5 FU); Colon cancer; Combinatorial approach; Curcumin (CUR); Drug delivery; N O carboxymethyl chitosan nanoparticles; Pharmacokinetics

Indexed keywords

EID: 84900884074     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2019.03.009     Document Type: Erratum

References (57)

1. American Cancer Society, Colorectal Cancer Facts & Figures 2011-2013, American Cancer Society, Atlanta, 2011.
2. http://globocan.iarc.fr/factsheets/cancers/colorectal.asp.
3. O. Glehen, F. Kwiatkowski, P.H. Sugarbaker, D. Elias, E.A. Levine, M.D. Simone, R. Barone, Y. Yonemura, F. Cavaliere, F. Quenet, M. Gutman, A.K. Tentes, G. Lorimier, J.L. Bernard, J.M. Bereder, J. Porcheron, A. Gomez-Portilla, P. Shen, M. Deraco, and P. Rat Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J. Clin. Oncol. 22 2004 3284 3292
4. M.H. Cohen, J. Gootenberg, P. Keegan, and R. Pazdur FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer Oncologist 12 2007 356 361
5. A. de Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortes-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Le Bail, C. Louvet, D. Hendler, F. de Braud, C. Wilson, F. Morvan, and A. Bonetti Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J. Clin. Oncol. 18 2000 2938 2947
6. D.B. Longley, D.P. Harkin, and P.G. Johnston 5-Fluorouracil: mechanisms of action and clinical strategies Nat. Rev. Cancer 3 2003 330 338
7. H.P. Klotz, W. Weder, and F. Largiader Local and systemic toxicity of intra-hepatic-arterial 5-FU and high-dose or low-dose leucovorin for liver metastases of colorectal cancer Surg. Oncol. 3 1994 11 16
8. J.R. Brown, and R.N. Du Bois COX-2: a molecular target for colorectal cancer prevention J. Clin. Oncol. 23 2005 2840 2855
9. H. Zhang, and X.F. Sun Over expression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer Am. J. Gastroenterol. 97 2002 1037 1041
10. Y. Sun, X.M. Tang, E. Half, M.T. Kuo, and F.A. Sinicrope Cyclooxygenase-2 over expression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells Cancer Res. 62 2002 6323 6328
11. N. Zhang, Y. Yin, S.J. Xu, and W.S. Chen 5-Fluorouracil: mechanisms of resistance and reversal strategies Molecules 13 2008 1551 1569
12. S. Tomozawa, N.H. Tsuno, E. Sunami, K. Hatano, J. Kitayama, T. Osada, S. Saito, T. Tsuruo, Y. Shibata, and H. Nagawa Cyclooxygenase-2 over expression correlates with tumour recurrence, especially haematogenous metastasis of colorectal cancer Br. J. Cancer 83 2000 324 328
13. O. Raul, P. Jose, M. Consolacion, L.A. Jose, M.A. Ruiz, J.A. Pablo, C. Octavio, L. Raquel, S. Ana, and A. Antonia 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer Int. J. Nanomed. 7 2012 95 107
14. C. Yan, J. Gu, Y. Guo, and D. Chen In vivo biodistribution for tumor targeting of 5-fluorouracil loaded N-succinyl chitosan nanoparticles Pharm. Soc. Jpn. 130 2010 801 804
15. Y. Zhang, J. Li, M. Lang, X. Tang, L. Li, and X. Shen Folate-functionalized nanoparticles for controlled 5-fluorouracil delivery J. Colloid Interface Sci. 354 2011 202 209
16. S. Li, A. Wang, W. Jiang, and Z. Guan Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles BMC Cancer 8 2008 103 10.1186/1471-2407-8-103
17. A.E.B. Yassin, M.K. Anwer, H.A. Mowafy, I.M. El-Bagory, M.A. Bayomi, and I.A. Alsarra Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer Int. J. Med. Sci. 7 2010 398 408
18. C.Y. Yu, Y.M. Wang, N.M. Li, G.S. Liu, S. Yang, G.T. Tang, D.X. He, W.W. Tan, and H. Wei In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy Mol. Pharm. 11 2014 638 644
19. B. Yu, Y. Zhang, W. Zheng, C. Fan, and T. Chen Positive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticles Inorg. Chem. 51 2012 8956 8963
20. S. Acharya, and S.K. Sahoo PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect Adv. Drug Deliv. Rev. 63 2011 170 183
21. K. Srimuangwong, C. Tocharus, P.Y. Chintana, A. Suksamrarn, and J. Tocharus Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells World J. Gastroenterol. 18 2012 2383 2389
22. B. Du, L. Jiang, Q. Xia, and L. Zhong Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29 Chemotherapy 52 2006 23 28
23. B.B. Patel, R. Sengupta, S. Qazi, H. Vachhani, Y. Yu, A.K. Rishi, and A.P. Majumdar Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R Int. J. Cancer 122 2008 267 273
24. K. Srimuangwong, C. Tocharus, J. Tocharus, A. Suksamrarn, and P.Y. Chintana Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats World J. Gastroenterol. 18 2012 6951 6959
25. J.Y. Koo, H.J. Kim, K.O. Jung, and K.Y. Park Curcumin inhibits the growth of AGS human gastric garcinoma cells in vitro and shows synergism with 5-fluorouracil J. Med. Food 7 2004 117 121
26. A. Shehzad, S. Khan, O. Shehzad, and Y.S. Lee Curcumin therapeutic promises and bioavailability in colorectal cancer Drugs Today 46 2010 523 532
27. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
28. Y.M. Tsai, C.F. Chien, L.C. Lin, and T.H. Tsai Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration Int. J. Pharm. 416 2011 331 338
29. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Curcumin nanoformulations: a future nanomedicine for cancer Drug Discov. Today 17 2012 71 80
30. P. Anand, H.B. Nair, B. Sung, A.B. Kunnumakkara, V.R. Yadav, R.R. Tekmal, and B.B. Aggarwal Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo Biochem. Pharmacol. 79 2010 330 338
31. Z. Song, R. Feng, M. Sun, C. Guo, Y. Gao, L. Li, and G. Zhai Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo J. Colloid Interface Sci. 354 2011 116 123
32. A. Anitha, V.V. Divya Rani, R. Krishna, V. Sreeja, N. Selvamurugan, S.V. Nair, S.V. Nair, H. Tamura, and R. Jayakumar Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, O-carboxymethyl and N,O-carboxymethyl chitosan nanoparticles Carbohydr. Polym. 78 2009 672 677
33. A. Anitha, S. Maya, N. Deepa, K.P. Chennazhi, S.V. Nair, and R. Jayakumar Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery J. Biomater. Sci. Polym. Ed. 23 2012 1381 1400
34. A. Anitha, K.P. Chennazhi, S.V. Nair, and R. Jayakumar 5-Flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer J. Biomed. Nanotechnol. 8 2012 29 42
35. X. Ma, Z. Cheng, Y. Jin, X. Liang, X. Yang, Z. Dai, and J. Tian SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy Biomaterials 35 2014 2878 2889
36. M. Reers, T.W. Smith, and L.B. Chen J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential Biochemistry 30 1991 4480 4486
37. M. Jung, G. Berger, U. Pohlen, S. Pauser, R. Reszka, and H.J. Buhr Simultaneous determination of 5-fluorouracil and its active metabolites in serum and tissue by high-performance liquid chromatography J. Chromatogr. B: Biomed. Sci. Appl. 702 1997 193 202
38. S.J. Choi, J.M. Oh, and J.H. Choy Biocompatible nanoparticles intercalated with anticancer drug for target delivery: pharmacokinetic and biodistribution study J. Nanosci. Nanotechnol. 10 2010 2913 2916
39. Z. Ma, A. Shayeganpour, D.R. Brocks, A. Lavasanifar, and J. Samuel High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin Biomed. Chromatogr. 21 2007 546 552
40. Y. Zhang, M. Huo, J. Zhou, and S. Xie PK Solver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel Comput. Methods Programs Biomed. 99 2010 306 314
41. K. Manjunath, and V. Venkateswarlu Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration J. Controlled Release 107 2005 215 228
42. C. Alexiou, W. Arnold, P. Hulin, R.J. Klein, H. Renz, F.G. Parak, C. Bergemann, and A.S. Lubbe Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting J. Magn. Magn. Mater. 225 2001 187 193
43. P. Huang, Z. Li, H. Hu, and D. Cui Synthesis and characterization of bovine serum albumin-conjugated copper sulfide nanocomposites Hindawi Publ. Corp.; J. Nanomater. 2010 10.1155/2010/641545
44. A. Anitha, N. Deepa, K.P. Chennazhi, S.V. Nair, H. Tamura, and R. Jayakumar Development of mucoadhesive thiolated chitosan nanoparticles for biomedical applications Carbohydr. Polym. 83 2011 66 73
45. R.C. Nagarwal, P.N. Singh, S. Kant, P. Maiti, and J.K. Pandit Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study Chem. Pharm. Bull. 59 2011 272 278
46. P.T. Ha, M.H. Le, T.M.N. Hoang, T. Thu, H. Le, T.Q. Duong, T.H.H. Tran, D.L. Tran, and X.P. Nguyen Preparation and anti-cancer activity of polymer-encapsulated curcumin nanoparticles Adv. Natl. Sci. Nanosci. Nanotechnol. 3 2012 035002
47. T. Kean, and M. Thanou Biodegradation, biodistribution and toxicity of chitosan Adv. Drug Deliv. Rev. 62 2010 3 11
48. E.R. Gillies, and J.M.J. Frechet PH-Responsive copolymer assemblies for controlled release of doxorubicin Bioconjugate Chem. 16 2005 361 368
49. H. Zhang, S. Mardyani, W.C.W. Chan, and E. Kumacheva Design of biocompatible chitosan microgels for targeted pH-mediated intracellular release of cancer therapeutics Biomacromolecules 7 2006 1568 1572
50. F.M. Gutierrez, E.P. Thi, J.M. Silverman, C.C. de Oliveira, S.L. Svensson, A.V. Hoek, E.M. Sanchez, N.E. Reiner, E.C. Gaynor, E.L.G. Pryzdial, E.M. Conway, E. Orrantia, F. Ruiz, Y. Av-Gay, and H. Bach Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles Nanomed. Nanotechnol. Biol. Med. 8 2012 328 336
51. M.L. Agarwal, W.R. Taylor, and M.V. Chernov The p53 network J. Biol. Chem. 273 1998 1 4
52. K.H. Kim, H.Y. Park, J.H. Nam, J.E. Park, J.Y. Kim, M.I. Park, K.O. Chung, K.Y. Park, and J.Y. Koo JY The inhibitory effect of curcumin on the growth of human colon cancer cells (HT-29, WiDr) in vitro, Korean J. Gastroenterol. 45 2005 277 284
53. T. Fang, F. Tianli, Z. Yan, J. Yanan, and Z. Xiaoyan Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-kB signaling pathway in vitro and in vivo Acta Biochim. Biophys. Sin. 44 2012 847 855
54. S.M. Mehdi, M. Ali, L. Cora, B. Franziska, S. Paviz, and G. Ajay Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways PLoS ONE 8 2013 e57218
55. S. Balasubramanian, A.R. Girija, Y. Nagaoka, S.I.M. Suzuki, V. Kizhikkilot, Y. Yoshida, T. Maekawa, and S.D. Nair Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia Int. J. Nanomed. 9 2014 437 459
56. R. Zhu, X. Wu, Y. Xiao, B. Gao, Q. Xie, H. Liu, and S. Wang Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line Cancer Biother. Radiopharm. 28 2013 579 587
57. P.D. King, and M.C. Perry Hepatotoxicity of chemotherapy Oncologist 6 2001 162 176